Favorable Results for Major Depressive Disorder Patients
Antony Loebel, MD, Executive Vice President and Chief Medical Officer, Sunovion Pharmaceuticals Inc. provided invaluable insight on the first placebo-controlled trial for patients with Major Depressive Disorder with mixed features.